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Wecompared the effects ofmedical and combined surgical andmedical treatment of refractory epilepsyon intellectual functioning
in a group of children (n = 13) and a group of adults (n = 15).
The patients were tested with the age-appropriate versions of Wechsler’s intelligence scales twice prior to and once after
epilepsy surgery. There were no signiﬁcant differences between the groups in preoperative epilepsy-related variables, including
age at onset. The IQ scores were submitted to two-way analyses of variance (ANOVA). We also evaluated individual changes
in IQ scores.
Adult patients maintained stable levels of performance after drug treatment as well as following surgery, while children
declined in Full Scale IQ after both kinds of treatment. Children also declined in Performance IQ, but not in Verbal IQ after drug
treatment, and in Verbal IQ, but not in Performance IQ after surgery. Three of six children who underwent a signiﬁcant decline
in Full Scale IQ before surgery did not show any further decline postoperatively.
We have proposed a developmental model to account for the different ﬁndings in children and adults, and conclude tentatively
that refractory, long-standing epilepsy may interfere with intellectual development both during drug treatment and following
combined surgical and medical treatment in children, while the impact of long-standing refractory epilepsy of similar severity
as in children is not strong enough to reduce intellectual performance in adults, irrespective of treatment modality.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Drug treatment has been the principal therapy for
epileptic seizures since the introduction of bromide
in 1857. Drugs have proven to be very effective. At
present about 80% of patients with epilepsy will ob-
tain seizure control on medication1. These results are
usually achieved without serious adverse effects on
cognition, particularly if the seizures are controlled
with one drug and blood serum levels are within the
recommended range2. However, about 20% of pa-
tients with epilepsy continue to have seizures despite
drug treatment3. The combined effect of seizures and
the use of one or more antiepileptic drugs (AEDs)
raise concerns about intellectual functioning. Several
recent follow-up studies of patients with medically
intractable epilepsy indicate that the risk for intel-
lectual decline may be considerable in children4–8,
while most adult patients seem to maintain a rela-
tively stable IQ7, 9, 10. Since the seizure disorders
in different studies are not described in comparable
units, however, one may argue that the children stud-
ied may have had a more severe epilepsy than the
adults. A common measure of seizure severity would
be warranted in order to clarify this issue.
Resective surgery aimed at eliminating epilep-
tic seizures has proven to be a good alternative to
drug treatment in carefully selected patients with
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medically refractory epilepsy. Approximately two
thirds of surgically treated patients become seizure
free, and in addition about 25% experience a worth-
while improvement11.
Although seizure control is the primary goal of
surgical treatment, a beneﬁcial effect on cognitive
functioning is supposed to occur, particularly in
children12, 13. Indeed, some surgically treated pa-
tients have experienced considerable intellectual
improvements14. In general, however, the postop-
erative changes in intellectual functioning in adults
appear to be modest. Apart from a moderate decline
in memory functions, particularly after left tempo-
ral lobe surgery, adult patients most often seem to
maintain stable test results15–17. The relatively few
studies performed in children do not indicate signif-
icant postoperative changes in mean Full Scale IQ
scores18–20. Westerveld et al.21 however, found a sig-
niﬁcant postoperative increase in Performance IQ in
children who underwent left temporal lobe surgery.
Furthermore, it has been suggested that patients who
decline in intellectual functioning during preoperative
drug treatment, may have the potential for a reversal
of the negative trend after surgery22–24. Such a pos-
itive effect has been reported in patients treated with
hemispherectomy25, but it is not clear whether a sim-
ilar result can be expected following focal resections.
We are aware of only one case study addressing this
question26. This study reported a postoperative im-
provement in Verbal IQ in a child treated with left
temporal lobectomy who went through a deterioration
in academic achievement preoperatively.
In the present study, we wanted to compare the
longitudinal effects of refractory seizures on intelli-
gence in children and adults over a period of drug
treatment and following surgery. Previous studies as-
sessing the effects on cognitive functioning of these
two kinds of treatment have compared patients un-
der consideration for surgery with patients who were
not surgical candidates10, 27. Such comparisons may
be of limited value, since these groups may differ
in variables with relevance for cognitive functions,
for example seizure frequency28, 29 or distribution
of epileptogenic tissue30, 31. The design adopted in
the present study circumvents such difﬁculties by
employing repeated assessments of the same patients
during presurgical drug treatment and after surgery.
This design also permits direct comparisons between
groups on epilepsy-related variables. There appears
to be no previously published study of this kind.
PATIENTS AND METHODS
Thirty-nine patients who had been tested twice before
and once after resective epilepsy surgery with age-
appropriate versions of Wechsler’s intelligence scales,
were considered for the study. The selection was
done retrospectively. At the ﬁrst assessment most
patients had an epilepsy which was not as yet recog-
nised as drug resistant, while some of them were in
an early phase of the preoperative work-up. Thirteen
patients were children (<18 years) when surgery was
performed, 15 were adults (≥18 years) at the ﬁrst
assessment. Eleven patients were children at the ﬁrst
assessment and adults at surgery. Because we wanted
to compare the effects of two types of treatment in
a group of paediatric patients to those in a group of
adults, these eleven patients were not included in the
study.
In a previous study32 we described the changes in
IQ scores in 34 children and adults over several years
with antiepileptic drug treatment for refractory seizure
disorders. The patients in the present study comprise
a sub-sample of this group who have subsequently
been treated surgically and completed our standard
follow-up assessment 2 years after surgery.
Surgical procedures
Twenty-four patients were treated by anterior tempo-
ral lobectomy including the foremost part of the hip-
pocampus in 19 cases. One adult patient underwent
a selective amygdalohippocampectomy and another
a temporo-occipital resection. Among the children,
one had a frontal lobe resection and another had
multilobar (temporoparietal) resections.
Epileptic seizures
For each patient the number and types of seizures
during the month preceding the two preoperative test
occasions were registered based either on the patients’
or the parents’ seizure calendars, or on records made
by the staff. Severity of the seizure activity in the
two groups was assessed by three experienced epilep-
tologists, who blindly and independently rated each
patient’s seizure records. Both seizure frequency and
seizures types were evaluated. Seizure activity prior
to Test 1 was rated using a graded ﬁve-point Likert
scale ranging from 0, ‘no seizures’, to 4, ‘very severe
seizure disorder’. The individual changes in seizure
severity during the preoperative test–retest interval
were also rated, using a seven-graded scale ranging
from −3 ‘much worse’ to +3 ‘much better’. The
inter-rater reliability was satisfactory in both ratings
(Kendall coefﬁcient of concordance 0.89, P < 0.001
and 0.94, P < 0.001, respectively). The rating proce-
dures are further described in Bjørnæs et al.32 Post-
operative seizure control was classiﬁed in accordance
with the suggestions made by Engel33 and coded in
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Arabic ﬁgures, with class IV a, b and c assigned the
values 4, 5, and 6, respectively.
EEG
Each patient’s EEG records prior to the preopera-
tive test occasions were blindly rated by a senior
neurophysiologist. Ratings considered degree and
distribution of pathology and included assessment of
background activity, focal slowing, sharp waves, and
spike and wave activity. A graded 5 point Likert scale
was used. Changes in EEG pathology from Test 1 to
Test 2 were rated according to a 7 point scale ranging
from −3, ‘much worse’ to +3, ‘much better’. At Test
3, EEG background activity, focal slow waves, and
epileptiform activity were evaluated separately using
5 point scales.
Antiepileptic drugs (AEDs)
During the preoperative test–retest period all patients
were treated with AEDs. Thirteen of the adults and
nine of the children had changes in the types of drugs
received in this period, but without obtaining seizure
control. Nine patients were on drug monotherapy at
Test 1, 14 at Test 2 and 14 at Test 3. Three patients
were without antiepileptic drugs at Test 1, none at Test
2, and 1 at Test 3. These patients were not excluded
from the study because they all had received drugs for
a substantial period of time pre- and post-operatively.
Test versions
The patients were tested with the age appropriate Nor-
wegian versions of the Wechsler Intelligence Scales.
Seven of the children were tested three times with
the Wechsler Intelligence Scales for Children-Revised
(WISC-R)34, while six children were ﬁrst tested with
the WISC-R and later with the Wechsler Adult Intel-
ligence Scale (WAIS)35. The adults were tested three
times with the WAIS. Standardisation of both versions
was done simultaneously in Norway, and the norm ta-
bles are assumed to be reasonably equivalent36. All
IQ scores were therefore included irrespective of the
version of the test used.
The interval between Test 1 and Test 2 was 4.3 years
on average. The average time elapsed from Test 2 to
surgery was 2.5 months, and Test 3 was performed on
average 2.1 years after surgery.
Test scores
Because the focus of interest was the long-term effects
of treatment on level of intelligence rather than cogni-
tive proﬁles, only summary IQ scores were considered
(i.e. Verbal, Performance, and Full Scale IQ scores).
Test–retest effects
Practice effects, i.e. a gain in IQ scores upon retest-
ing, are demonstrated in normal adults37 as well as
in normal children38. Such changes are also seen
in groups of patients with epilepsy on stable drug
treatment39. However, test–retest gains seem to be ei-
ther absent40 or negligible41 in patients with frequent
epileptic seizures. In accordance with these previous
studies, we did not anticipate substantial practice ef-
fects in the present study, because our patients had
severe refractory seizures, and because test–retest
intervals were relatively long42. Besides, potential
practice effects would probably be present in both
groups, and not compromise comparisons between
groups.
Another possible confounding factor in the study of
cognitive change is regression toward the mean43. This
statistical artefact signiﬁcantly inﬂuences the results if
initial test scores are signiﬁcantly inversely correlated
to the measures of change44. This was not the case in
the present study. Thus, no corrections for regression
effects were considered necessary.
Individual changes
In addition to average changes in IQ scores based on
the group data, we wanted to study individual changes.
But because all patients underwent active drug treat-
ment with changes in types, number, or dosages of
AEDs, we could not isolate error variance from the
treatment effects. Consequently, individual changes
had to be described in arbitrarily chosen values, as
previously done in the studies by Bourgeois et al.45
and Gilliam et al.46 In accordance with these studies,
IQ scores equal to or greater than ±10 points were
deemed presumably reliable individual changes.
Statistical methods
Categorical data were analysed using the Chi-square
test wherever the requirements for this test were
met. The Fisher exact test was used in 2 × 2 con-
tingency tables with few patients. Ordinal-scale data
and continuous data with large differences between
the groups with respect to error variance were com-
pared among groups using the median test. Where
appropriate, continuous demographic variables were
analysed by Student’s t-test for independent samples.
Verbal, Performance, and Full Scale IQ scores were
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separately submitted to repeated-measures analyses
of variance, with group as independent variable and
test occasion as repeated-measures factor. Post hoc
tests were performed using Duncan’s multiple range
test. P-values less than 0.05 in two-tailed tests were
considered statistically signiﬁcant. The statistical
analyses were run with Statistica for Windows47.
RESULTS
Demographic and seizure-related variables
At Test 1, the children were on average 10.2 years
of age, and the adults were 24.6. When surgery was
performed, the children and adults were on average
14.0 and 29.6 years of age, respectively (Table 1).
The adults had had their epilepsy signiﬁcantly longer
than the children at both preoperative test occasions
(median 5.5 and 9.3 years in the children, 12.7 and
18.8 years in the adults, respectively).
However, there were no signiﬁcant differences be-
tween children and adults with respect to epilepsy-
related variables such as aetiology, age at onset of
seizures, number of generalised tonic–clonic and
complex partial seizures prior to the test occasions,
laterality or location of the epileptic focus, EEG
pathology and seizure severity prior to Test 1, nor in
Table 1: Demographic and epilepsy-related variables.
Children (n = 13) Adults (n = 15) P
Sex, m/f 8/5 9/6 NSa
Etiology: cryptogenic/symptomatic 9/4 9/6 NSb
Laterality of epileptic focus: left/right 7/6 7/8 NSa
Age at seizure onset (years), median (qr) 5.0 (5.0) 10.0 (13.0) NSc
Duration of epilepsy at Test 1 (years), median (qr) 5.5 (5.2) 12.7 (11.6) <0.01c
Age at Test 1 (years), mean (SD) 10.2 (2.7) 254.6 (4.7)
CPS/month at Test 1, median (qr) 11.0 (69.0) 9.0 (15.0) NSc
GTC/month at Test 1, median (qr) 0.0 (0.0) 0.1 (2.0) NSc
Seizure severity at Test 1, median (qr) 3.0 (2.0) 2.3 (1.3) NSc
EEG pathology at Test 1, median (qr) 2.0 (2.0) 2.0 (1.0) NSc
Time Test 1–Test 2 (years), mean (SD) 3.5 (2.7) 5.0 (3.8) NSd
Duration of epilepsy at Test 2 (years), median (qr) 9.3 (6.3) 18.8 (15.9) <0.01c
CPS/month at Test 2, median (qr) 20.0 (81.0) 9.0 (10.0) NSc
GTC/month at Test 2, median (qr) 0.0 (3.0) 0.1 (4.0) NSc
Change in EEG-pathology Test 1–Test 2, median (qr) −2.0 (2.0) 0.0 (1.0) NSc
Change in seizure severity Test 1–Test 2, median (qr) 1.0 (6.0) 1.0 (9.0) NSc
Age at operation (years), mean (SD) 14.0 (2.6) 29.7 (5.4)
Temporal/extratemporal resections 11/2 14/1 NSb
Time op to Test 3 (years), median (qr) 2.1 (0.2) 2.0 (0.1) NSc
Postoperative seizure control, median (qr) 2.0 (3.0) 3.0 (3.0) NSc
EEG pathology at Test 3 (postoperative)
Background activity, median (qr) 0.0 (1.0) 0.0 (1.0) NSc
Focal slow activity, median (qr) 1.0 (0.0) 1.0 (1.0) NSc
Epileptiform activity, median (qr) 0.0 (1.0) 0.0 (1.0) NSc
Abbreviations: m, male; f, female; crypt, cryptogenic; symp, symptomatic; SD, standard deviation; CPS, complex partial seizures; GTC,
generalized tonic–clonic seizures; qr, quartile range; op, operation; EEG, electroencephalogram; NS, not signiﬁcant.
a Chi-square test; b Fisher exact; c Median test; d t-test for independent samples.
preoperative changes in EEG pathology and seizure
severity. Furthermore, we found no signiﬁcant dif-
ferences between the groups in postoperative seizure
control or EEG pathology. The preoperative test–retest
interval, and the postoperative follow-up interval
did not differ between groups. In short, differences
between the groups were primarily related to age.
IQ scores
Mean IQ scores at the three test sessions are shown
in Table 2. The analysis of variance revealed no
Table 2: Mean IQ scores and standard deviations.
Test 1 Test 2 Test 3
VIQ
Children 89.7 (18.4) 84.9 (20.6) 76.0 (18.0)
Adults 81.9 (17.7) 84.8 (19.2) 85.8 (18.6)
PIQ
Children 93.7 (15.7) 87.4 (17.1) 86.6 (19.6)
Adults 76.1 (20.2) 82.7 (18.5) 81.9 (23.1)
FSIQ
Children 90.5 (17.1) 84.3 (19.8) 78.6 (18.9)
Adults 77.6 (19.2) 82.5 (19.0) 83.5 (18.8)
Abbreviations: VIQ, Verbal IQ; PIQ, Performance IQ; FSIQ,
Full Scale IQ.
Intellectual functioning, surgical and medical treatment 477
Table 3: Individual changes in IQ scores (number of patients experiencing gains, losses or stable IQ scores).
Verbal IQ Performance IQ Full Scale IQ
Gains Stable Losses Gains Stable Losses Gains Stable Losses
Drug treatment
Children 1 7 5 1 7 5 1 6 6
Adults 4 11 0 5 10 0 3 12 0
Drugs + surgical treatment
Children 0 7 6 3 6 4 1 7 5
Adults 2 12 1 3 9 3 1 13 1
signiﬁcant group effects, but a signiﬁcant effect of
test occasion was found in Verbal IQ scores, mainly
due to the appreciable decline in the children’s scores
(F(2, 52) = 3.3, P < 0.05). Moreover, signiﬁcant
interaction effects between groups and test sessions
were found in Verbal IQ (F(2, 52) = 9.4, P < 0.001),
Performance IQ (F(2, 52) = 4.4, P < 0.05), and Full
Scale IQ (F(2, 52) = 9.8, P < 0.001), showing that
the descending trend in IQ scores in the children was
signiﬁcantly different from the ascending trend in the
adults.
Post hoc tests of within-group changes showed a
statistically signiﬁcant decline in FSIQ scores from
Test 1 to Test 2 in the children (P < 0.05). In addition,
there was a signiﬁcant decline in Verbal IQ scores in
the children from Test 2 to Test 3 (P < 0.01). In the
adults, there were no signiﬁcant changes in any of the
IQ scores between Test 1 and 2, nor between Test 2 and
3. Between-group comparisons showed no signiﬁcant
differences in Verbal, Performance and Full Scale IQ
scores at any of the test sessions.
Individual changes
When comparing the effects on intelligence of drug
treatment versus combined treatment with drugs and
surgery in terms of individual changes, we found no
substantial differences in any of the IQ scores. For
example, six patients (21%) declined by 10 or more
points in Full Scale IQ scores after drug treatment
(Table 3), four patients (14%) experienced gains,
while 18 patients (64%) had no substantial change in
their scores. After surgery, six patients (21%) declined
in FSIQ, two (7%) showed gains, while 20 (71%)
maintained a stable performance. Similar results were
found in Verbal and Performance IQ scores.
The six patients who experienced a drop in FSIQ
scores of 10 or more points during drug treatment were
all children (46%). None in the adult group showed
a comparable decline. One child and three adults in-
creased their FSIQ scores. With the results shown in
Table 3 arranged in a 2 × 2 contingency table with
the categories ‘stable’ and ‘gains’ collapsed, these
differences between the groups achieved statistical
signiﬁcance (P < 0.01, Fisher exact test). The differ-
ences between the groups in Verbal and Performance
IQ scores were also signiﬁcant (P-values < 0.05).
These results indicate that the risk for a signiﬁcant de-
cline in Verbal, Performance, and Full Scale IQ scores
during the period with drug treatment was greater in
the paediatric than the adult group. After surgery, sim-
ilar analyses showed that signiﬁcantly more children
than adults declined in Verbal IQ (P < 0.03), but not
in Performance or Full Scale IQ (P-values > 0.05).
Analyses of the number of patients experiencing
gains in IQ scores revealed no signiﬁcant differences
between the groups after drug treatment or after
surgery (all P-values > 0.1, the category ‘gains’ vs.
the categories ‘stable’ and ‘losses’ collapsed, Table 3).
Thus, the likelihood of an increase in IQ scores was
not different for children and adults.
Of the six children who declined in Full Scale IQ
before surgery, the downward trend was reversed after
surgery in three. All of these children became seizure
free (Engel class I)33. However, the downward trend
persisted in three children. Two of these patients had
no reduction in seizure frequency 2 years after surgery
(Engel class IVb)33. One, however, was seizure free.
DISCUSSION
The present results show that there was no mean de-
cline in IQ in the sample of adult patients during the
preoperative period (5 years on average) with drug
treatment, despite a refractory seizure disorder which
was sufﬁciently severe to warrant surgical treatment.
They also maintained a relatively stable level of intel-
lectual functioning at the assessment 2 years after sur-
gical treatment. These results are in agreement with
several longitudinal studies of intelligence in adult
patients with refractory epilepsy treated either with
antiepileptic drugs7, 9, 10, 39, or with the combination
of drugs and surgery7, 10, 48.
Recurrent refractory seizures in children, on the
other hand, seem to have a negative impact on intelli-
gence. In the present study, serial testing during drug
treatment over the average preoperative period of 3.5
years showed a signiﬁcant mean decline in Full Scale
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IQ. These results are in line with the ﬁndings in pre-
vious follow-up studies of children with refractory
epileptic seizures4–6, 49. After surgery, however, there
was no signiﬁcant decline in Performance or Full
Scale IQ, although a decline was seen in Verbal IQ
scores. A greater risk for decline in Verbal than Per-
formance IQ following epilepsy surgery has also been
found in some previous studies in adult patients50, 51.
We found no indications that the children had more
severe seizure conditions or more progressive courses
than the adults preoperatively, nor did we ﬁnd differ-
ences between the groups with respect to postoperative
variables with potential effect on intelligence, namely
seizure control and EEG (Table 1). It should be noted,
however, that ﬁndings concerning the role played by
postoperative seizure control for cognitive function-
ing are equivocal. Leonard51, for example, found that
adult patients with good seizure control performed bet-
ter than those with poor seizure control on a variety of
cognitive measures including tests of intelligence, and
Lieb et al.41 reported impairment in Full Scale IQ in
63 % of adult patients with poor postoperative seizure
relief. On the other hand, in a study of Westerveld
et al.21 seizure relief was not signiﬁcantly predictive
of postoperative change in IQ scores in children. One
recent study have shown that the postoperative EEG
may have predictive value for cognitive functioning52.
Even though several follow-up studies have des-
cribed a decline in IQ scores in children with refrac-
tory epilepsy, the way the changes progress is not well
known. The issue was addressed in a study by Neyens
et al.8 who administered intelligence tests three times
with approximately 6 months test–retest intervals to
children with epilepsy. They found a relatively decline
in children with epilepsy compared to controls, and
this decline was greater in children with a recent onset
of seizures than in those who had a longer duration
of epilepsy. The investigators interpreted the results
to partly support a cascadic model for intellectual
deterioration. According to this model children with
epilepsy are supposed to show a process of mental
deterioration shortly after the onset of epilepsy. The
results in our sample of children with medically re-
fractory seizures do not ﬁt well into this model. There
were no signiﬁcant correlations between duration of
epilepsy at Test 1 and changes in IQ scores from
Test 1 to Test 2 (P-values > 0.7). Inspection of the
scatterplots revealed one extreme outlier, a child who
increased the Verbal, Performance and Full Scale IQ
scores by 31, 18, and 29 points, respectively. Even
with this case removed, the correlations were not sig-
niﬁcant (P-values > 0.8). On the other hand, with the
outlier removed from the data set a signiﬁcant negative
correlation was obtained between the duration of the
preoperative test–retest interval and changes in Verbal
IQ scores (P < 0.02), and close to signiﬁcant corre-
Fig. 1: Changes in Verbal (a); Performance (b); and Full
Scale (c) IQ scores with different peroperative test–retest
intervals (years) in children.
lations with Full Scale IQ scores (P < 0.06) (Fig. 1).
As our sample of children had had their epilepsy for
more than 5 years on average at the ﬁrst assessment,
these results suggest that changes in intelligence
may follow an approximately linear trend for several
years. One explanation of the differences between the
study by Neyens et al.8 and the present one may be
related to differences in the severity of the seizure
disorder, as six of the 11 children in the former study
responded well to drug treatment and were seizure
free at the end of the follow-up period, while this was
not the case preoperatively in any of our children.
Since the present data suggest that changes in IQ
scores may follow a linear course, pre- and postoper-
ative follow-up intervals of the same length would be
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preferable. This was, however, not possible to secure
as the selection of patients was done retrospectively.
The preoperative test–retest interval was 4 years and
the postoperative follow-up interval was 2.1 years, on
average. To take these differences into consideration
we adjusted the individual IQ scores at Test 1 in all
patients as if the pre- and postoperative test–retest in-
tervals were equal, using linear interpolation. If IQ1,
IQ2, and IQ3 were IQ scores at Test 1, Test 2 and Test
3, respectively, the new (recomputed) IQ score at Test
1 was: IQ1new = IQ2 − ((IQ2 − IQ1/(T2 − T1))×
(T3− T2)) where T1, T2 and T3 were points of time
of the respective test sessions. A similar analysis of
variance as performed above with these adjusted IQ
scores at Test 1 gave essentially the same results: no
group effects, a signiﬁcant test effect for Verbal IQ
(F(2, 52) = 5.0, P < 0.02) and signiﬁcant interaction
effects in Verbal IQ (F(2, 52) = 12.8, P < 0.001),
Performance IQ (F(2, 52) = 5.4, P < 0.01) and Full
Scale IQ (F(2, 52) = 12.9, P < 0.001). Two alter-
ations occurred, however, in the post hoc test results:
The preoperative decline in Performance IQ and the
postoperative decline in Full Scale IQ became signif-
icant in the children (both P-values < 0.05).
The joint conclusions to be drawn from these two
analyses are that Verbal, Performance, and Full Scale
IQ scores follow signiﬁcantly different courses in
children and adults. In children, IQ scores from serial
testing show a decline, while adults maintain IQ scores
at a stable level. Furthermore, children may be more
at risk for a decline in Performance than Verbal IQ
during drug treatment, while the situation seems to be
the other way round following surgery. As Verbal and
Performance subscales are all entered into the calcu-
lation of Full Scale IQ scores, both kinds of treatment
pose a risk for decline in general intelligence in the
children.
Individual changes
Drug treatment versus surgery
The proportions of patients undergoing changes in
IQ scores equal to or greater than 10 points were
largely the same during drug treatment and following
surgery (Table 3). About 40% of the children declined
both pre- and postoperatively, while most adults ob-
tained stable results. Only one patient in each group
experienced a gain in Full Scale IQ scores. These
ﬁndings illustrate that the prospects for a substan-
tial improvement in intellectual functioning following
surgery may be modest even in seizure free patients
(n = 12), in line with previous ﬁndings in children21
and in adults15, 16. Drug withdrawal would probably
not make any great difference53, 54.
Effects of surgery on preoperative cognitive decline
This question have been addressed in a case study by
Jambaqué et al.26, who found a postoperative increase
in Verbal IQ following left temporal lobectomy in a
child who had gone through a preoperative deterio-
ration in academic achievement. To our knowledge,
this is the only previous report of a reversal of a pre-
operative decline in functioning subsequent to a focal
resection. In a study of intellectual change in chil-
dren treated by lesionectomy Bourgeois et al.52 found
indices of a progressive preoperative cognitive dete-
rioration in 18%, and a postoperative improvement in
25% of children who became seizure free. Unfortu-
nately, the postoperative outcome in the children who
declined preoperatively was not reported separately.
In the present study, we found no further decline in
three of six children who had experienced a signiﬁ-
cant preoperative drop in Full Scale IQ. These three
children were all seizure free 2 years after surgery
(Engel class Ia). All of them had been treated with
temporal lobectomy, one left and two right. Two of
the three children who continued to decline had no re-
duction in seizure frequency after surgery (class IVb).
They were both treated with temporal lobectomy, one
left and one right. The third child who declined was
seizure free, but had gone through a multilobar re-
section in the left hemisphere, and was the only one
who developed a permanent postoperative neurologi-
cal deﬁcit. The present results thus lend some support
to the supposition that epilepsy surgery may arrest
an ongoing preoperative intellectual deterioration in
patients who become seizure free.
A developmental model
Changes in IQ scores may have different implications
in children and adults. We have previously proposed
a developmental model to account for the different
courses in intellectual functioning in the two groups32.
Refractory epilepsy seems to retard the intellectual de-
velopment in many of our children, which is reﬂected
in a diminishing IQ, while the impact of recurrent
seizures is not severe enough to reduce intellectual
functioning substantially in adults, at least not adults
with relatively early onset of seizures.
Methodological considerations
Ideally, the comparison of medical and surgical treat-
ment should be done prospectively in controlled
clinical trials with patients who are randomised ei-
ther to a prolongation of medical treatment before
surgery, or to immediate surgery. This also would
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make it possible to secure pre- and postoperative ob-
servation periods of equal length. Such an approach
was chosen in a recent study by Wiebe et al.55 who
randomly assigned patients to surgery or treatment
with antiepileptic drugs for 1 year. Effects on seizures
and quality of life were considered. The investigators
concluded that surgery is clearly superior to drug
treatment with respect to both outcome measures.
However, this approach is controversial, because
of the risks inherent in the diagnosis of medically
intractable seizures56, 57.
The retrospective approach chosen in the present
study, although avoiding ethical concerns and prob-
lems with respect to differences between surgical and
non-surgical groups of patients, may limit the general-
isability of ﬁndings. As the patients had been referred
to the epilepsy centre several years prior to the preop-
erative evaluation, they might have had a more serious
epilepsy than is usually found in the population of sur-
gical candidates. This may be one reason why children
in the present study as a group had a poorer prognosis
with respect to pre- to post-postoperative intellectual
changes than reported in previous studies19, 58, 59.
The ﬁndings by Austin et al.60 that children with
high as opposed to low initial seizure severity con-
tinued to obtain low scores in academic achievement
despite improvement in the seizure condition, support
this view.
Another prognostic factor for postoperative change
in cognitive functioning in which our group of chil-
dren seems to differ from many previous studies is the
preoperative duration of epilepsy19, 46, 52, 61. Meyer
et al.61 clearly demonstrated that the chance for a
positive postoperative change was inversely related
to the preoperative duration of epilepsy. Inspection of
their data shows that the risk for a negative change
is drastically increased when preoperative duration of
epilepsy exceeds 7 years. This may be another reason
why so many children in the present study experi-
enced a drop in postoperative IQ, since the duration of
epilepsy when surgery was performed was 9 years on
average.
A comparison between the patients selected for the
present study and the remaining 132 surgical can-
didates at the time of the preoperative assessment
showed that the selected patients had a signiﬁcantly
earlier age at onset of seizures (7.4 vs. 11.5 years,
t = 2.2, P < 0.05, t-test for independent samples)
and were younger than the remaining patients (22.2
vs. 29.4 years, t = 3.2, P < 0.01). On the other
hand, duration of epilepsy, Verbal, Performance, and
Full Scale IQ scores did not vary signiﬁcantly between
groups (all P-values > 0.4). Thus, our results may
apply mainly to relatively young surgical candidates
with early onset of refractory seizures, and, presum-
ably, a relatively severe seizure condition.
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